The Muir-Torre syndrome: a 25-year retrospect
- PMID: 7601953
- DOI: 10.1016/0190-9622(95)90017-9
The Muir-Torre syndrome: a 25-year retrospect
Abstract
The Torre or Muir-Torre syndrome consists of certain types of sebaceous neoplasms of the skin, with or without keratoacanthomas, and one or more low-grade visceral malignancies in the absence of other predisposing factors. The sebaceous tumors are relatively uncommon or rare: sebaceous adenoma, sebaceous epithelioma, basal cell epithelioma with sebaceous differentiation, and sebaceous carcinoma. Sebaceous hyperplasia and hamartomas such as nevus sebaceus of Jadassohn, with or without a sebaceous epithelioma within it, are not a defining part of this syndrome. Sebaceous hyperplasia is common in elderly light-complexioned people with or without this syndrome. Nevus sebaceus of Jadassohn is not rare and is predisposed to the development of other neoplasms within it, including occasionally a sebaceous epithelioma. Colonic polyps are frequently present. Muir-Torre syndrome requires recognition because affected patients are at risk of multiple primary malignancies. The skin lesions may be the first sign of this syndrome, although more often its cutaneous signs follow the diagnosis of at least the first visceral malignancy. The Muir-Torre syndrome portends the greater possibility of a favorable prognosis than might be anticipated otherwise because the visceral cancers are usually low-grade malignancies. However, they are often multiple, so identifying such patients will affect their management in a few ways. Because these indolent visceral malignancies tend to permit prolonged survival, even metastatic disease may respond well to aggressive surgical treatment. The sebaceous cancers in this syndrome, like the visceral malignancies, are less aggressive than their counterparts unassociated with this syndrome. Because this syndrome is inherited in an autosomal dominant manner, identifying one patient means delineating an entire family, which should be investigated. This syndrome may be caused by a defective mismatch DNA repair gene.
Comment in
-
Muir-Torre syndrome and defective DNA mismatch repair genes.J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):493-4. doi: 10.1016/s0190-9622(96)90644-1. J Am Acad Dermatol. 1996. PMID: 8784301 No abstract available.
Similar articles
-
Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.J Cutan Pathol. 2009 Jun;36(6):613-9. doi: 10.1111/j.1600-0560.2009.01248.x. J Cutan Pathol. 2009. PMID: 19515040 Review.
-
Muir-Torre syndrome.Ann Plast Surg. 1998 Jun;40(6):676-7. doi: 10.1097/00000637-199806000-00020. Ann Plast Surg. 1998. PMID: 9641292
-
The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms.Dermatologica. 1989;178(1):23-8. doi: 10.1159/000248381. Dermatologica. 1989. PMID: 2917677
-
Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports.Dermatol Online J. 2024 Mar 15;30(1). doi: 10.5070/D330163287. Dermatol Online J. 2024. PMID: 38762859
-
Muir-Torre syndrome.Lancet Oncol. 2005 Dec;6(12):980-7. doi: 10.1016/S1470-2045(05)70465-4. Lancet Oncol. 2005. PMID: 16321766 Review.
Cited by
-
Just another chalazion?Indian J Ophthalmol. 2019 Feb;67(2):195. doi: 10.4103/ijo.IJO_18_19. Indian J Ophthalmol. 2019. PMID: 30672468 Free PMC article. No abstract available.
-
External auditory canal sebaceous carcinoma.BMJ Case Rep. 2023 Sep 29;16(9):e255038. doi: 10.1136/bcr-2023-255038. BMJ Case Rep. 2023. PMID: 37775279 Free PMC article.
-
Simultaneous Muir-Torre and Turcot's syndrome: A case report and review of the literature.Surg Neurol Int. 2013 Apr 12;4:52. doi: 10.4103/2152-7806.110512. Print 2013. Surg Neurol Int. 2013. PMID: 23646262 Free PMC article.
-
Extraocular sebaceous carcinoma mimicking benign sebaceous cyst.BMJ Case Rep. 2013 Jan 29;2013:bcr2012008176. doi: 10.1136/bcr-2012-008176. BMJ Case Rep. 2013. PMID: 23365173 Free PMC article.
-
Paraneoplastic dermatological manifestation of gastrointestinal malignancies.World J Gastroenterol. 2009 Sep 21;15(35):4372-9. doi: 10.3748/wjg.15.4372. World J Gastroenterol. 2009. PMID: 19764087 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases